Comparative Pharmacology
Head-to-head clinical analysis: DEXTROSE 4 IN MODIFIED LACTATED RINGER S IN PLASTIC CONTAINER versus DEXTROSE 5 AND RINGER S IN PLASTIC CONTAINER.
Peer-Reviewed Evidence
Head-to-head clinical analysis: DEXTROSE 4 IN MODIFIED LACTATED RINGER S IN PLASTIC CONTAINER versus DEXTROSE 5 AND RINGER S IN PLASTIC CONTAINER.
DEXTROSE 4% IN MODIFIED LACTATED RINGER'S IN PLASTIC CONTAINER vs DEXTROSE 5% AND RINGER'S IN PLASTIC CONTAINER
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Dextrose provides glucose for cellular energy metabolism. Lactated Ringer's solution replaces extracellular fluid and electrolytes. Lactate is metabolized to bicarbonate in the liver, providing buffering capacity for metabolic acidosis.
Dextrose provides a source of calories and water for hydration, and Ringer's solution provides electrolytes to maintain fluid and electrolyte balance. The combination is used to restore intravascular volume and correct metabolic acidosis.
Intravenous infusion; adult dose is 500-1000 mL per 24 hours, titrated to fluid and electrolyte needs.
Intravenous administration at a rate determined by fluid and electrolyte needs; typical adult rate is 100-200 mL/hour, not to exceed 25 g dextrose per hour (500 mL/hour of D5LR).
None Documented
None Documented
2–4 hours (intravenous). Clinical context: reflects glucose clearance; prolonged in renal impairment.
Dextrose: not applicable as it is rapidly metabolized; clinical effect depends on glucose utilization. Ringer's components: distribution half-life ~20-30 minutes; elimination half-life determined by renal function, typically 2-4 hours for electrolyte adjustments.
Renal: >99% as glucose. Biliary/fecal: negligible (<1%).
Dextrose: primarily metabolized to CO2 and water; <5% excreted unchanged in urine. Ringer's solution: electrolytes (Na, K, Ca, Cl) excreted renally; water excreted via kidneys, lungs, and skin.
Category C
Category C
IV Fluid
IV Fluid